Clinical Trials Logo

Adductor Spasmodic Dysphonia clinical trials

View clinical trials related to Adductor Spasmodic Dysphonia.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03129087 Enrolling by invitation - Clinical trials for Adductor Spasmodic Dysphonia

The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia

Start date: May 23, 2017
Phase: N/A
Study type: Interventional

This study will compare the effects of vocal rest versus continuous vocalization for one hour immediately following botulinum toxin injections for adductor spasmodic dysphonia.